Bibliografías temáticas / PNEUMOCOCCO / Libros
Siga este enlace para ver otros tipos de publicaciones sobre el tema: PNEUMOCOCCO.

Libros sobre el tema "PNEUMOCOCCO"

Autor: Grafiati
Publicado: 10 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 50 mejores mejores libros para su investigación sobre el tema "PNEUMOCOCCO".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore libros sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Siber, George R., Keith P. Klugman y P. Helena Mäkelä, eds. Pneumococcal Vaccines. Washington, DC, USA: ASM Press, 2008. http://dx.doi.org/10.1128/9781555815820.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Tuomanen, Elaine I., Timothy J. Mitchell, Donald Morrison y Brian G. Spratt, eds. The Pneumococcus. Washington, DC, USA: ASM Press, 2004. http://dx.doi.org/10.1128/9781555816537.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

I, Tuomanen Elaine, ed. The pneumococcus. Washington, DC: ASM Press, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

King, Samantha Jane. Epidemiology and evolution of pneumococcal neuraminidases. [s.l.]: typescript, 1999.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

T, Mayon-White Richard y Royal Society of Medicine (Great Britain), eds. The clinical impact of pneumococcal disease and strategies for its prevention: Proceedings of an international conference sponsored by Pasteur Merieux MSD held at the Royal Society of Medicine, London, 13 December 1994. London, UK: Royal Society of Medicine Press, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

R, Siber George, Klugman Keith P y Mäkelä P. Helena, eds. Pneumococcal vaccines: The impact of conjugate vaccine. Washington, DC: ASM Press, 2008.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Riddiough, Michael A. Implications of alternative Medicare payment methods for pneumoccal vaccination. Washington, DC: Health Program, Office of Technology Assessment, U.S. Congress, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Riddiough, Michael A. Implications of alternative Medicare payment methods for pneumoccal vaccination. Washington, DC: Health Program, Office of Technology Assessment, U.S. Congress, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Nuorti, J. Pekka. Prevention of pneumococcal disease among infants and children: Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: Dept. of Health and Human Services, Centers for Disease Control and Prevention, 2010.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Riddiough, Michael A. Implications of alternative Medicare payment methods for pneumoccal vaccination. Washington, DC: Health Program, Office of Technology Assessment, U.S. Congress, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
11

Aging, National Institute on, ed. Pneumonia prevention: It's worth a shot. [Gaithersburg, MD]: National Institute of Aging, 1996.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
12

Parker, James N. y Philip M. Parker. The official patient's sourcebook on pneumonia. San Diego, Calif: Icon Health Publications, 2002.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
13

Life with the pneumococcus: Notes from the bedside, laboratory, and library. Philadelphia: University of Pennsylvania Press, 1985.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
14

Centers for Medicare & Medicaid Services (U.S.), ed. Medicare preventive services: Adult immunizations : a guide to billing influenza and pneumococcal vaccinations. [Baltimore, Md.]: Centers for Medicare & Medicaid Services, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
15

Siriwardena, Aloysius Niroshan. The impact of educational interventions on influenza and pneumococcal vaccination rates in primary care. Leicester: De Montfort University, 2003.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
16

Travers, Jasmine. Infection Control and Racial/Ethnic Disparities in Influenza and Pneumococcal Vaccination in Nursing Homes. [New York, N.Y.?]: [publisher not identified], 2016.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
17

Paul, John. Microbiological aspects of pneumococcal disease in patients infected with human immunodeficiency virus in Nairobi, Kenya. Birmingham: University of Birmingham, 1999.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
18

Pneumonia before antibiotics: Therapeutic evolution and evaluation in twentieth-century America. Baltimore: Johns Hopkins University Press, 2006.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
19

Office, General Accounting. Immunization: HHS could do more to increase vaccination among older adults : report to Congressional requesters. Washington, D.C: The Office, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
20

Officer, Great Britain Department of Health Chief Medical. Adult immunisation update: (i) introduction of a pneumococcal immunisation programme for those aged 80 years and over : (ii) influenza immunisation programme 2003/2004. London: Department of Health, 2003.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
21

New York Academy of Sciences. Pharmaceutical science to improve the human condition: Prix Galien 2011 : winners and finalist candidate of the Prix Galien USA Awards 2011. Malden, MA: Wiley Periodicals, 2012.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
22

Spratt, Brian G., Donald Morrison, Elaine I. Tuomanen y Timothy J. Mitchell. Pneumococcus. Wiley & Sons, Limited, John, 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
23

The pneumococcus. Washington, DC: ASM Press, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
24

(Editor), Elaine I. Tuomanen, Timothy J. Mitchell (Editor), Donald Morrison (Editor) y Brian G. Spratt (Editor), eds. The Pneumococcus. ASM Press, 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
25

Pneumococcal Infections. Oxford University Press, 2008.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
26

CALDERA, David. Prevnar (pneumococcal). Independently Published, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
27

Bai, Guangchun y Jorge Eugenio Vidal, eds. Molecular Pathogenesis of Pneumococcus. Frontiers Media SA, 2017. http://dx.doi.org/10.3389/978-2-88945-278-1.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
28

Yamaguchi, Masaya, Yuki Kinjo y Victor Nizet. Host-pathogen Interaction During Pneumococcal Infections. Frontier Media SA, 2021. http://dx.doi.org/10.3389/978-2-88971-888-7.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
29

The Clinical Impact of Pneumococcal Disease And Strategies for Its Prevention (International Congress & Symposium). Royal Society of Medicine Press Ltd, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
30

Mäkelä, P. Helena, George R. Siber y Keith P. Klugman. Pneumococcal Vaccines: The Impact of Conjugate Vaccines. Wiley & Sons, Limited, John, 2014.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
31

Kumar, Deepali. Immunogenicity of pneumococcal vaccination in renal transplant recipients. 2004.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
32

Jeurissen, Axel. Regulation of the Antibody Response to Pneumococcal Capsular Polysaccharides. Leuven Univ Pr, 2005.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
33

Pneumococcal Vaccines - Recent Advances, New Perspectives and Applications [Working Title]. IntechOpen, 2023. http://dx.doi.org/10.5772/intechopen.102200.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
34

Weinberger, Daniel Martin. Factors affecting the carriage and disease patterns of pneumococcal serotypes. 2010.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
35

Implementation of Vaccine Policy (International Congress and Symposium). Royal Society of Medicine Press, 2007.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
36

Peters, Jennifer Ann. FOSTERING INFLUENZA AND PNEUMOCOCCAL IMMUNIZATION: A NURSING INTERVENTION FOR OLDER ADULTS. 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
37

Watson, D. The Pneumococcus: Epidemology, Prophylaxis, Treatment and Virulence (Medical Intelligence Unit Series). R. G. Landes, 1999.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
38

Austrian, Robert y Lewis Thomas. Life with the Pneumococcus: Notes from the Bedside, Laboratory, and Library. University of Pennsylvania Press, 2016.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
39

Vu, Kathy. Understanding the factors affecting influenza and pneumococcal vaccination in cardiac patients. 2000.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
40

van Assen, Sander y Marc Bijl. Vaccination in immunocompromised adults. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0094.

Texto completo
Resumen
This chapter addresses all important questions regarding vaccination of patients with autoimmune inflammatory rheumatic diseases (AIIRD). First, the incidence of vaccine-preventable infections in these patients is discussed. Pulmonary infections, including influenza and pneumococcal infection, occur more often in AIIRD patients; herpes zoster and human papillomavirus are also more frequent. The efficacy of vaccination for all European registered vaccines is discussed. Treatment with disease-modifying anti-rheumatic drugs (DMARDs) and biologicals (in particular TNFα‎-blocking agents) do not hamper, or only slightly hamper, the immune responses to most vaccines. Rituximab is an exception, severely reducing humoral responses following influenza and pneumococcal vaccination, at least during the first 6 months after administration. Safety of vaccination is an important issue in patients with autoimmune diseases, since increased disease activity of the underlying disease as a result of vaccination is theoretically possible. The available evidence is summarized, suggesting that vaccination is safe in AIIRD patients. Live vaccines, however, are contraindicated in immunosuppressed patients with AIIRD. Finally, the European League Against Rheumatism (EULAR) recommendations are highlighted, summarizing the 'do's' and 'don'ts' of vaccination in adults with AIIRD.
Los estilos APA, Harvard, Vancouver, ISO, etc.
41

Harrison, Mark. Principles of immunization. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198765875.003.0012.

Texto completo
Resumen
This chapter describes the principles of microbiology immunization as they apply to Emergency Medicine, and in particular the Primary FRCEM examination. The chapter outlines the key details of immunization schedules for diphtheria, tetanus, pertussis, Haemophilus influenzae type b, polio, Pneumococcal infection, MMR, meningitis C, HPV, varicella, hepatitis B, and influenza, as well as further sources of information. This chapter is laid out exactly following the RCEM syllabus, to allow easy reference and consolidation of learning.
Los estilos APA, Harvard, Vancouver, ISO, etc.
42

The Biology of Pneumococcus; the Bacteriological, Biochemical, and Immunological Characters and Activities of Diplococcus Pneumoniae. Franklin Classics, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
43

MD, Benjamin White, Elliott Stirling Robinson y Laverne Almon Barnes. The Biology of Pneumococcus; The Bacteriological, Biochemical, and Immunological Characters and Activities of Diplococcus Pneumoniae. Franklin Classics Trade Press, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
44

MD, Benjamin White, Elliott Stirling Robinson y Laverne Almon Barnes. The Biology of Pneumococcus; The Bacteriological, Biochemical, and Immunological Characters and Activities of Diplococcus Pneumoniae. Franklin Classics Trade Press, 2018.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
45

Podolsky, Scott H. Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America. Johns Hopkins University Press, 2006.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
46

Immunization: HHS could do more to increase vaccination among older adults : report to Congressional requesters. Washington, D.C. (P.O. Box 37050, Washington 20013): The Office, 1995.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
47

Torres, Antoni y Adamantia Liapikou. Diagnosis and management of community-acquired pneumonia. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0116.

Texto completo
Resumen
Severe community-acquired pneumonia (SCAP) remains the most common infectious reason for admission to the intensive care unit (ICU), reaching a mortality rate of 30–40%. The microbial pattern of the SCAP has changed with S. pneumoniae still the leading pathogen, but a decrease of atypical pathogens, especially Legionella and an increase of viral and polymicrobial pneumonias. IDSA/ATS issued guidelines on the management of CAP including specific criteria to identify patients for ICU admission with good predictive value. The first selection of antimicrobial therapy should be started early covering all likely pathogens, depending on the presence of the risk factors for Pseudomonas aeruginosa infection. Combination therapy may be useful in patients with non-refractory septic shock and severe sepsis pneumococcal bacteraemia as well. The challenges include the emergence of new pathogens as community-acquired methicillin-resistant Staphylococcus aureus, new influenza virus subtypes and the high prevalence of multidrug resistance, mainly from institutionalizing patients.
Los estilos APA, Harvard, Vancouver, ISO, etc.
48

Heijstek, Marloes, Mario Abinun y Nico Wulffraat. Vaccination in immunocompromised children. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0095.

Texto completo
Resumen
Can immunocompromised children be safely and effectively vaccinated? This chapter discusses the recommendations from the European League Against Rheumatism (EULAR) for the immunization of immunocompromised patients. Patients with rheumatic or autoinflammatory diseases treated with high-dose glucocorticoids, high-dose disease-modifying anti-rheumatic drugs (DMARDs), or biologicals are considered immunocompromised. Safe and effective vaccination is crucial in these patients, given their increased risk of infection. Safe vaccination implies that vaccination has no effect on disease activity and has only mild adverse effects. Effective vaccination denotes that patients are protected against infections after immunization. Particularly in severely immunosuppressed patients, concerns arise on the safety of (live-attenuated) vaccines and on the detrimental effect of immunosuppressive treatment on the immunogenicity of vaccines. Overall, vaccinations do not increase disease activity and do not cause severe adverse events. Although non-live vaccines are safe, it is recommended to withhold live-attenuated vaccines in patients on high-dose immunosuppressive drugs and biologicals. However, booster vaccinations can be considered when essential. Generally, immunogenicity of vaccines is good with some exceptions: responses are reduced in patients on high-dose glucocorticoids and rituximab; methotrexate reduces responses to (pneumococcal) polysaccharide vaccines; and anti-tumour necrosis factor alpha (TNFα‎) may lower vaccine-induced antibody concentrations. Offering vaccination before immunosuppressive drugs and/or measuring antibodies after immunization is recommended.
Los estilos APA, Harvard, Vancouver, ISO, etc.
49

Heijstek, Marloes, Mario Abinun y Nico Wulffraat. Vaccination in immunocompromised children. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199642489.003.0095_update_003.

Texto completo
Resumen
Can immunocompromised children be safely and effectively vaccinated? This chapter discusses the recommendations from the European League Against Rheumatism (EULAR) for the immunization of immunocompromised patients. Patients with rheumatic or autoinflammatory diseases treated with high-dose glucocorticoids, high-dose disease-modifying antirheumatic drugs (DMARDs), or biologicals are considered immunocompromised. Safe and effective vaccination is crucial in these patients, given their increased risk of infection. Safe vaccination implies that vaccination has no effect on disease activity and has only mild adverse effects. Effective vaccination denotes that patients are protected against infections after immunization. Particularly in severely immunosuppressed patients, concerns arise on the safety of (live-attenuated) vaccines and on the detrimental effect of immunosuppressive treatment on the immunogenicity of vaccines. Overall, vaccinations do not increase disease activity and do not cause severe adverse events. It is recommended to withhold live-attenuated vaccines in patients on high-dose immunosuppressive drugs and biologicals, but booster vaccinations can be considered when essential. Generally, immunogenicity of vaccines is good with some exceptions: responses are reduced in patients on high-dose glucocorticoids and rituximab; methotrexate reduces responses to (pneumococcal) polysaccharide vaccines; and tumour necrosis factor alpha (TNFα‎) may lower vaccine-induced antibody concentrations and may cause accelerated waning of immunity. Offering vaccination before immunosuppressive drugs and/or measuring antibodies after immunization is recommended.
Los estilos APA, Harvard, Vancouver, ISO, etc.
50

Tomasz, Alexander, ed. Streptococcus Pneumoniae: Molecular Biology & Mechanisms of Disease. MARY ANN LIEBERT PUBLISHING, 2000.

Buscar texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías sobre el tema "PNEUMOCOCCO" para otros tipos de fuentes:
Artículos de revistas Tesis
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía